fred hochberg

Fred Hochberg is a prominent figure in both business and biotechnology. He is currently the President of Exosome Analytics, a company focused on vesicular research and applications.3 With a background in neurology and neuro-oncology, Dr. Hochberg has extensive experience in translating laboratory findings into therapies for patients with brain diseases.46

Professional Background

Biotechnology Ventures:: Dr. Hochberg is the Principal of three early-stage biotechnology companies that provide therapeutics and diagnostics in the vesicular field.3 His work involves novel approaches to diagnosing brain diseases, collaborating with teams in San Diego, Baltimore, and Boston.4

Medical Career:: Prior to his current role, Dr. Hochberg was a neurologist at Partners HealthCare, though he is now retired from that position.5 His expertise lies in neurology and neuro-oncology, with a particular focus on brain diseases.6

Academic Affiliation:: Dr. Hochberg has ties to Columbia University in the City of New York.5

Research and Innovation

Dr. Hochberg's work in the field of exosomes and microvesicles has contributed to advancements in diagnostics and therapeutics. The exosome industry has seen significant growth in recent years, with applications in both diagnostics and therapeutics.2 His involvement in multiple biotechnology companies suggests a strong commitment to innovation in this field.

It's worth noting that while there is another Fred P. Hochberg known for his work in government and business leadership1, the Fred Hochberg associated with Exosome Analytics is distinct and primarily focused on medical research and biotechnology entrepreneurship.